Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
64 participants
OBSERVATIONAL
2014-04-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be recruited from a well-characterised cohort, previously assembled during their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in 2001-2004.
Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus rendering the possibility of longitudinal assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969
Serum Markers in Preeclamptic Women
NCT01361737
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposed
Women with a history of preeclampsia 10 years ago
No interventions assigned to this group
Unexposed
Women with a history of uncomplicated pregnancy 10 years ago
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Randers Regional Hospital
OTHER
Karen Elise Jensen Foundation
OTHER
Central Denmark Region
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulla B Knudsen, Professor
Role: STUDY_CHAIR
Department of Obstetrics and Gynaecology, Aarhus University Hospital
Martin Christensen, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research Unit, Randers Regional Hospital
Camilla S Kronborg, MD, PhD
Role: STUDY_DIRECTOR
Department of Oncology, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Randers Regional Hospital
Randers, Randers NØ, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
98372017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.